Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10002238HBVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS10040173HBVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS10023013HBVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS10027973HBVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS30015531HIVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS30015532HIVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS30002788HIVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS30010517HIVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS30002789HIVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS30012366HIVENSG00000178607.17protein_codingERN1NoNo2081O75460
TCGA Plot Options
Drug Information
GeneERN1
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0003839
UniProt IDO75460
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830